Registration number: 07755790

Apres Labs

Contents

Company Information	1
Accountants' Report	2
Balance Sheet	3
Notes to the Unaudited Financial Statements	4 to 7

Apres Labs

Company Information

Director

Dr Graham Moores

Registered office

Research And Innovation Campus Rothamsted, West Common Harpenden Herts AL5 2JQ

Accountants

IA Accountants 9 Barlings Road Harpenden Herts AL5 2AL

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Apres Labs
for the Year Ended 31 August 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Apres Labs for the year ended 31 August 2023 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Apres Labs, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Apres Labs and state those matters that we have agreed to state to the Board of Directors of Apres Labs, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Apres Labs and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Apres Labs has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Apres Labs. You consider that Apres Labs is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Apres Labs. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

IA Accountants
9 Barlings Road
Harpenden
Herts
AL5 2AL

30 September 2023

Apres Labs

(Registration number: 07755790)
Balance Sheet as at 31 August 2023

	Note	2023 £	2022 £
Fixed assets
Tangible assets	4	4,003	8,875
Current assets
Debtors	5	5,301	14,509
Cash at bank and in hand		122,277	133,174
		127,578	147,683
Creditors: Amounts falling due within one year	6	(6,322)	(10,114)
Net current assets		121,256	137,569
Net assets		125,259	146,444
Capital and reserves
Called up share capital		2	2
Retained earnings		125,257	146,442
Shareholders' funds		125,259	146,444

For the financial year ending 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 30 September 2023
 

......................................... Dr Graham Moores Director

Apres Labs

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2023

1	General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Research And Innovation Campus Rothamsted, West Common
Harpenden
Herts
AL5 2JQ
United Kingdom

These financial statements were authorised for issue by the director on 30 September 2023.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Apres Labs

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Other Tangible Assets	25 % Reducing Balance
Furniture, Fittings and Equipment	15% Reducing Balance
Furniture, Fittings and Equipment (Computers)	33% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

Apres Labs

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2023

4	Tangible assets

	Furniture, fittings and equipment  £	Other tangible assets £	Total £
Cost or valuation
At 1 September 2022	2,353	25,811	28,164
At 31 August 2023	2,353	25,811	28,164
Depreciation
At 1 September 2022	2,353	16,936	19,289
Charge for the year	-	4,872	4,872
At 31 August 2023	2,353	21,808	24,161
Carrying amount
At 31 August 2023	-	4,003	4,003
At 31 August 2022	-	8,875	8,875

5

Debtors

Current	2023 £	2022 £
Trade debtors	2,460	12,160
Prepayments	670	670
Other debtors	2,171	1,679
	5,301	14,509

6

Creditors

Creditors: amounts falling due within one year

	2023 £	2022 £
Due within one year
Trade creditors	858	465
Taxation and social security	2,320	7,117
Other creditors	3,144	2,532
	6,322	10,114

Apres Labs

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2023